Further analysis of clinical tissue data revealed that high SUN5 expression was associated with poor differentiation and lymph node metastasis, indicating that SUN5 may be a potential biomarker for CRC clinic diagnosis. This evidence concerns the gene SUN5 and colorectal carcinoma.